ScreenerHero

CDXSCodexis, Inc.

NAS · US · Healthcare · Biotechnology · codexis.com
1.670USD+4.38%Mkt Cap: 182.87M $P/E: —

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap182.87M $
Enterprise Value190.69M $
Revenue (TTM)77.68M $
Gross Profit61.05M $
Net Income (TTM)-43.97M $
Revenue/Share0.8570 USD
Last Price1.670 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees146
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS1920051067
Valuation
P/E (Trailing)—
P/E (Forward)-4.94
PEG13.53
EV/EBITDA-10.01
EV/Revenue2.45
P/S2.23
P/B4.38
EPS (TTM)-0.33
EPS (Forward)-0.32
52W Range
0.960033% of range3.120
52W High3.120 USD
52W Low0.9600 USD
Profitability
Gross Margin86.73%
Oper. Margin-75.29%
EBITDA Margin-24.52%
Profit Margin-62.47%
ROE-87.03%
ROA-29.75%
Growth
Revenue Growth-2.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.38M $
CapEx (TTM)4.47M $
FCF Margin2.74%
FCF Yield1.16%
Net Debt17.67M $
Net Debt/EBITDA-0.93
Balance Sheet
Debt/Equity1.45
Current Ratio3.06
Quick Ratio2.83
Book Value/Sh0.3610 USD
Cash/Share0.5020 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.333 USD
Upside (mean)+279.2%
Target Range2.000 USD – 11.00 USD
$2.000+279.2% to mean$11.00
# Analysts6
Ownership
Shares Out.109.51M
Float82.35M
Insiders6.15%
Institutions70.42%
Short Interest
Short Ratio2.9d
Short % Float3.70%
Short % Out.3.65%
Shares Short3.93M
Short (prev mo.)3.23M
Technical
SMA 502.015 (-17.1%)
SMA 2001.899 (-12.0%)
Beta2.50
S&P 52W Chg18.16%
Avg Vol (30d)1.33M
Avg Vol (10d)1.33M
Technical Indicators
RSI (14)46.3
MACD-0.1260
MACD Signal-0.1758
MACD Hist.+0.0498
BB Upper1.792 USD
BB Middle1.538 USD
BB Lower1.283 USD
BB Width33.14%
ATR (14)0.1181 USD
Vol Ratio (20d)0.74x